Use your antibodies-online credentials, if available.
抗Human Complement Factor H 抗体:
抗Mouse (Murine) Complement Factor H 抗体:
抗Rat (Rattus) Complement Factor H 抗体:
Human Monoclonal Complement Factor H Primary Antibody for IP, ELISA - ABIN2473069
Fontaine, Demares, Koistinen, Day, Davrinche, Sim, Ripoche: Truncated forms of human complement factor H. in The Biochemical journal 1989
Show all 4 Pubmed References
Human Polyclonal Complement Factor H Primary Antibody for ELISA, WB - ABIN250548
Klein, Zeiss, Chew, Tsai, Sackler, Haynes, Henning, SanGiovanni, Mane, Mayne, Bracken, Ferris, Ott, Barnstable, Hoh: Complement factor H polymorphism in age-related macular degeneration. in Science (New York, N.Y.) 2005
Human Polyclonal Complement Factor H Primary Antibody for ID, WB - ABIN253380
Radu, Hu, Yuan, Welch, Makshanoff, Lloyd, McMullen, Travis, Bok: Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration. in The Journal of biological chemistry 2011
Human Monoclonal Complement Factor H Primary Antibody for IHC (fro), FACS - ABIN2473067
Harrison, Lachmann: The physiological breakdown of the third component of human complement. in Molecular immunology 1980
Show all 2 Pubmed References
inhibition of the alternative pathway by factor H, with a concentration equivalent to a high physiological level, strongly reduced C5a levels and decreased proinflammatory cytokine production in human peripheral blood mononuclear cells.
Complement factor H Y402H (rs1061170) and age-related maculopathy susceptibility2 (ARMS2 (显示 ARMS2 抗体))/LOC387715 A69S (rs10490924) polymorphisms shown to have significant association with age-related macular degeneration (Meta-Analysis).
Regression analysis showed that ARMS2 (显示 ARMS2 抗体) TT genotype has a statistically significant effect on retinal angiomatous proliferation versus age-related macular degeneration compared to CFH genotypes (P < 0.001).
This study enclosed strong synergistic association of risk genotypes of C3 and CFH Y402H with AMD (显示 AMD1 抗体). We also revealed synergistic influence of CCL2 (显示 CCL2 抗体)-2518 and the at-risk genotype of the C3 in AMD (显示 AMD1 抗体) with an estimated AP = 50.9% (adjusted AP = 24.7%). Present findings show that CCL2 (显示 CCL2 抗体)-2518 polymorphism is not an innocent bystander (显示 SEPT1 抗体) in AMD (显示 AMD1 抗体) susceptibility when combined with the at-risk genotype of C3 (R102G).
Our results suggest that factor H can interfere with mycobacterial entry into macrophages and modulate inflammatory cytokine responses, particularly during the initial stages of infection, thus affecting the extracellular survival of the pathogen.
To our knowledge, this is the first evaluation of the involvement of the CFHR3 (显示 CFHR3 抗体)/CFHR1 (显示 CFHR1 抗体) deletion and age-related macular degeneration in CFH Y402H polymorphism Brazilian patients.
The findings of the present study provide evidence that CFH gene variants and ARMS2 (显示 ARMS2 抗体)/HTRA1 (显示 HTRA1 抗体) genes play a major role in the genetic susceptibility to AMD (显示 AMD1 抗体) in a Greek population. These findings are of direct relevance for disease and help mapping the genetic chart of AMD (显示 AMD1 抗体).
Our results suggest the contribution of all four predicted CFH polymorphisms in age-related macular degeneration (AMD (显示 AMD1 抗体)) susceptibility among the Iranian population. This association with CFH may lead to early detection and new strategies for prevention and treatment of AMD (显示 AMD1 抗体).
Development of polypoidal choroidal vasculopathy (PCV) in the unaffected fellow eye is associated with ARMS2 (显示 ARMS2 抗体) A69S genotype in patients with unilateral PCV.
Identification of rare CFH variant carriers may be important for upcoming complement-inhibiting therapies. Patients with an extensive drusen area, drusen with crystalline appearance, and drusen nasal to the optic disc are more likely to have a rare variant in the CFH gene.
this study shows that complement regulatory protein (显示 TGFB1 抗体) Factor H is a soluble prion (显示 PRNP 抗体) receptor that potentiates peripheral prion (显示 PRNP 抗体) pathogenesis
Factor H and Crry (显示 CR1L 抗体) are critical for regulating complement activation at distinct anatomic sites within the kidney.
VEGF (显示 VEGFA 抗体) inhibition decreases local CFH and other complement regulators in the eye and kidney through reduced VEGFR2 (显示 KDR 抗体)/PKC-alpha (显示 PKCa 抗体)/CREB (显示 CREB1 抗体) signaling.
environmental factors can drive retinal disease in these mice when linked to complement deficits impairing immune function. Both groups of mice had similar levels of retinal amyloid beta accumulation. Consequently there is no direct link between this and inflammation in Cfh(-/-) mice.
absence of plasma CfH conferred susceptibility to glomerulonephritis
This new understanding of the complicated interactions of CFH in AMD (显示 AMD1 抗体)-like pathology provides an improved foundation for the development of targeted therapies for AMD (显示 AMD1 抗体)
data suggest that altered interactions of Cfh with MDA-modified proteins may be relevant in explaining the effects of the Cfh variant.
Cfh and Cfhr2 (显示 CFHR2 抗体) genes are expressed in the mouse outer retina. Only Cfh mRNA was detected in the retinal pigment epithelium, but no protein.
A spectrum of complement dysregulation was modeled on the APOE4 age related macular degeneration mouse model by crossing these mice to complement factor H knockout (cfh-/-) mice to test the impact of excess complement activation.
Data indicate that co-deficiency of factor H (FH) and MASP-1/MASP-3 (显示 MASP1 抗体) did not ameliorate either the plasma Complement C3 (显示 C3 抗体) (C3) activation or glomerular C3 accumulation in FH-deficient mice.
interaction between sialylated Neisseria gonorrhoeae and factor H [factor H]
Results report the molecular cloning and identification of complement factor H and complement factor H-like 1-4 (CFHL1 (显示 CFHR1 抗体)-4) in Danio rerio.
This gene is a member of the Regulator of Complement Activation (RCA) gene cluster and encodes a protein with twenty short consensus repeat (SCR) domains. This protein is secreted into the bloodstream and has an essential role in the regulation of complement activation, restricting this innate defense mechanism to microbial infections. Mutations in this gene have been associated with hemolytic-uremic syndrome (HUS) and chronic hypocomplementemic nephropathy. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.
H factor 1 (complement)
, H factor 2 (complement)
, adrenomedullin binding protein
, age-related maculopathy susceptibility 1
, factor H
, factor H-like 1
, complement regulator factor H
, complement factor H
, complement factor H related protein 3A4/5G4
, protein beta-1-H
, complement component factor H
, complement inhibitory factor H
, platelet complement factor H
, complement factor H L homeolog